- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Glofitamab, Poseltinib, Lenalidomide
Total 1075 results
-
University of ArkansasWithdrawn
-
Dana-Farber Cancer InstituteBristol-Myers SquibbNo longer availableMultiple Myeloma | Multiple Myeloma in RelapseUnited States
-
GenmabAbbVieActive, not recruitingFollicular Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | High-grade B-cell Lymphoma | Primary Mediastinal Large B Cell LymphomaJapan
-
Hackensack Meridian HealthMerck Sharp & Dohme LLCCompletedMultiple MyelomaUnited States
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited Kingdom, United States, France, Netherlands, Denmark
-
TakedaCompletedRelapsed and/or Refractory Multiple MyelomaJapan
-
TakedaTerminatedRelapsed and/or Refractory Multiple Myeloma
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaHong Kong, Korea, Republic of, Singapore
-
National Cancer Institute (NCI)CompletedMetastatic Prostate CancerUnited States
-
Gruppo Italiano Studio LinfomiUnknown
-
Henan Cancer HospitalActive, not recruitingDiffuse Large B Cell LymphomaChina
-
National Cancer Institute (NCI)Active, not recruitingPrimary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS) | Aggressive B-cell Lymphoma With Secondary Involvement of the CNSUnited States
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedPlasma Cell Myeloma | Hematopoietic Cell Transplantation RecipientUnited States
-
CelgeneCompletedMultiple MyelomaUnited States, Canada, Germany, Spain, Denmark, Netherlands, Finland, Italy
-
Raija SilvennoinenTakeda; Celgene; Nordic Myeloma Study GroupActive, not recruitingMultiple MyelomaNorway, Sweden, Finland, Lithuania
-
TakedaCompletedRelapsed and/or Refractory Multiple MyelomaJapan
-
Millennium Pharmaceuticals, Inc.Completed
-
Massachusetts General HospitalCelgene CorporationTerminatedAcute Myelogenous Leukemia | Acute Myeloid Leukemia (AML) | Acute Myelocytic Leukemia | Acute Granulocytic Leukemia | Acute Non-Lymphocytic LeukemiaUnited States
-
Cantonal Hospital of St. GallenCelgene Corporation; Amgen; Mundipharma Medical Company; Mundipharma Research GmbH...Completed
-
Beth ChristianGenentech, Inc.; CelgeneActive, not recruitingRecurrent Marginal Zone Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Burkitt Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Burkitt Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma and other conditionsUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieAmgenCompletedMultiple MyelomaAustria, Germany
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingPlasma Cell MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.TerminatedLymphoma, Non-HodgkinUnited States, Canada
-
CelgeneCompletedDiffuse Large B-cell LymphomaUnited States, Australia, Italy, Spain, France, Austria, Sweden, Czechia, United Kingdom
-
Ajai ChariNovartis PharmaceuticalsCompletedMultiple MyelomaUnited States
-
Hearn Jay ChoBristol-Myers SquibbCompletedMultiple MyelomaUnited States
-
Leap Therapeutics, Inc.CompletedMultiple MyelomaUnited States
-
Massachusetts General HospitalCompleted
-
University of Colorado, DenverTerminatedRefractory Plasma Cell MyelomaUnited States
-
City of Hope Medical CenterCompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Smoldering Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)WithdrawnMultiple Myeloma | Plasma Cell MyelomaUnited States
-
University of CologneIncyte CorporationNot yet recruitingNon-Hodgkin LymphomaGermany
-
Massachusetts General HospitalCelgeneCompleted
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.; CelgeneActive, not recruiting
-
Joseph TuscanoNational Cancer Institute (NCI); CelgeneActive, not recruitingRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Chronic Lymphocytic Leukemia | Refractory Hairy Cell Leukemia | Refractory Mantle Cell Lymphoma | Recurrent... and other conditionsUnited States
-
Hackensack Meridian HealthTerminatedMultiple MyelomaUnited States
-
TakedaCompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States, Canada
-
Second Affiliated Hospital, School of Medicine,...CompletedPrimary Central Nervous System LymphomaChina
-
TakedaCompleted
-
Millennium Pharmaceuticals, Inc.Completed
-
PETHEMA FoundationMillennium Pharmaceuticals, Inc.; CelgeneCompleted
-
Hospital Universitari Vall d'Hebron Research InstituteCompleted
-
Hellenic Society of HematologyGlaxoSmithKlineRecruitingNeoplasms | Multiple Myeloma | Paraproteinemias | Blood Protein Disorders | Corneal Disease | Gammopathy, Monoclonal | Haematologic Disease | Neoplasm, Plasma CellGreece
-
Peking Union Medical College HospitalRecruitingPrimary Intraocular LymphomaChina
-
University Hospital, ToulouseRecruiting
-
Fred Hutchinson Cancer CenterActive, not recruitingPlasma Cell Myeloma | Transplant-Related CarcinomaUnited States
-
TakedaActive, not recruiting